GO:0032807 DNA ligase IV complex: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032807 (DNA ligase IV complex) is a eukaryotically conserved protein complex that contains DNA ligase IV and XRCC4 (or its homolog, such as Saccharomyces Lif1p) and is required for DNA repair by non-homologous end joining (NHEJ).
• The complex is recruited to DNA double-strand breaks by the Ku70/Ku80 heterodimer, which directly interacts with XRCC4-ligase IV.
• DNA ligase IV is the catalytic subunit that seals the DNA ends, but its catalytic activity is not absolutely required for all repair outcomes; catalytically inactive ligase IV can still promote repair in living cells.
• Beyond catalysis, DNA ligase IV has a structural role that guides end-processing choice and promotes the fidelity of NHEJ [2,7].
• The complex is essential for V(D)J recombination, class-switch recombination, and maintenance of genomic stability, and its dysfunction is linked to immunodeficiency and cancer predisposition [1,2,7].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are powerful tools to dissect the functions of DNA ligase IV complex components in human cells [1,2,5].
Description
The DNA ligase IV complex (GO:0032807) is a multi-protein assembly that carries out the final ligation step of non-homologous end joining (NHEJ), the predominant pathway for repairing DNA double-strand breaks in mammalian cells. The complex is defined by the presence of DNA ligase IV (LIG4) and XRCC4 (or its yeast homolog Lif1p), and it is recruited to broken DNA ends through an interaction with the Ku70/Ku80 heterodimer. This recruitment is a critical early step that channels breaks into the NHEJ pathway and influences how DNA ends are processed before ligation [7,8]. Researchers study the DNA ligase IV complex because it sits at the intersection of genome stability, immune system development, and cancer biology [1,2,7]. Defects in the complex cause a spectrum of human diseases, including severe combined immunodeficiency with radiosensitivity, and cells lacking functional ligase IV are hypersensitive to DNA-damaging agents [1,2]. Moreover, recent work has shown that the complex has functions beyond its catalytic ligation activity, including a structural role in promoting NHEJ fidelity and guiding end-processing decisions [2,7]. Understanding these functions requires precise genetic tools, and CRISPR-based cell models are now widely used to dissect the contributions of each component [1,2,5].
DNA ligase IV complex At A Glance
| GO ID | GO:0032807 |
|---|---|
| GO term | DNA ligase IV complex |
| Ontology | cellular_component |
| Synonym | DNA ligase IV-XRCC4 complex |
| Major function | DNA repair by non-homologous end joining (NHEJ) |
| Core components | DNA ligase IV (LIG4) and XRCC4 (or Saccharomyces Lif1p) |
| Recruitment factor | Ku70/Ku80 heterodimer |
| Conservation | Eukaryotically conserved |
| Associated processes | V(D)J recombination, class-switch recombination, genome stability [1,2,7] |
What Is GO:0032807?
The DNA ligase IV complex is a eukaryotically conserved protein complex that contains DNA ligase IV and is involved in DNA repair by non-homologous end joining; in addition to the ligase, the complex also contains XRCC4 or a homolog, e.g. Saccharomyces Lif1p. In simpler terms, it is the molecular machine that seals broken DNA ends during a major DNA repair pathway, and it is built from at least two core proteins: the enzyme that does the sealing (ligase IV) and a partner (XRCC4) that helps the enzyme work and localize correctly.
Why Is DNA ligase IV complex Important in Cell Biology?
The DNA ligase IV complex is essential for maintaining genomic integrity because it performs the final ligation step of NHEJ, the primary pathway for repairing DNA double-strand breaks in human cells. Without this complex, cells cannot efficiently repair breaks, leading to hypersensitivity to ionizing radiation and chemotherapeutic agents, and in humans, defects in ligase IV or XRCC4 cause immunodeficiency and cancer predisposition [1,2,7]. Beyond its canonical role, the complex also influences the choice of DNA end-processing during NHEJ, thereby affecting the fidelity of repair and the risk of mutations [2,7]. Thus, understanding its structure, regulation, and function is critical for cancer biology, immunology, and the development of targeted therapies.
• The complex is required for V(D)J recombination, which generates diverse T-cell receptors and antibodies; defects cause severe combined immunodeficiency.
• It is the main ligase for NHEJ, the dominant double-strand break repair pathway in mammalian cells.
• Loss of function leads to radiosensitivity and increased cancer predisposition [1,2].
• The complex guides end-processing choice, influencing repair fidelity and mutation risk.
• Catalytically inactive ligase IV can still promote repair, revealing non-catalytic functions.
• DNA ligase IV has a structural role in promoting NHEJ fidelity.
• The complex is a target for cancer therapy because cancer cells often rely on NHEJ for survival.
• CRISPR screens have identified LIG4 and XRCC4 as essential for resistance to DNA-damaging agents.
• The complex interacts with other repair factors, such as DNA polymerase β, affecting repair pathway choice.
• Studying the complex provides insights into genome editing outcomes, as NHEJ competes with homology-directed repair.
What Happens During DNA ligase IV complex?
Recruitment to DNA double-strand breaks
In simple terms: The complex is called to the site of a DNA break by a sensor protein.
The Ku70/Ku80 heterodimer binds to DNA ends and recruits the XRCC4-ligase IV complex to the break site. This interaction is essential for NHEJ and ensures that the ligase is positioned at the damage.
End processing and alignment
In simple terms: Before sealing, the broken ends may need to be trimmed or modified.
DNA ligase IV guides the choice of end-processing during NHEJ, influencing whether ends are trimmed by nucleases or filled in by polymerases. This decision affects the fidelity of repair and the final sequence at the junction.
Ligation of DNA ends
In simple terms: The enzyme ligase IV seals the break by joining the DNA strands.
DNA ligase IV catalyzes the formation of a phosphodiester bond between the DNA ends, completing the repair. However, catalytically inactive ligase IV can still promote repair in living cells, indicating that the complex has additional non-catalytic functions.
Fidelity control and structural role
In simple terms: The complex also ensures that the repair is as accurate as possible.
DNA ligase IV has a structural role in promoting the fidelity of NHEJ, beyond its catalytic activity. This function helps minimize errors during repair and is critical for maintaining genome stability.
Key Genes Involved in GO:0032807 DNA ligase IV complex
The following genes and proteins are key components or interactors of the DNA ligase IV complex (GO:0032807) and are frequently studied in the context of NHEJ and genome stability.
| Gene | Major Role | Research Relevance |
|---|---|---|
| LIG4 | Catalytic subunit of the complex; seals DNA ends | Mutations cause immunodeficiency and radiosensitivity; target for CRISPR KO and point mutation studies [1,2] |
| XRCC4 | Essential partner of ligase IV; stabilizes and stimulates ligase activity | Required for NHEJ; knockout leads to severe repair defects |
| KU70 (XRCC6) | DNA end-binding subunit of Ku heterodimer; recruits XRCC4-LIG4 | Key for recruitment; knockout abolishes NHEJ |
| KU80 (XRCC5) | DNA end-binding subunit of Ku heterodimer; recruits XRCC4-LIG4 | Key for recruitment; knockout abolishes NHEJ |
| Lif1p (yeast) | Yeast homolog of XRCC4; forms complex with Lig4p | Model for studying conserved NHEJ mechanisms |
| POLB | DNA polymerase beta; involved in base excision repair and backup NHEJ | Genetic interactions with NHEJ ligase; knockout sensitizes to DNA damage |
| XRCC1 | Scaffold protein in base excision repair; prevents PARP1 trapping | Interacts with ligase III, not ligase IV, but relevant for repair pathway crosstalk |
| PARP1 | Poly(ADP-ribose) polymerase; involved in DNA damage response | PARP1 trapping is toxic; XRCC1 prevents it; relevant for cancer therapy |
| YY1 | Transcription factor; involved in extrachromosomal DNA biogenesis with Lig3 | Not directly in ligase IV complex but highlights ligase diversity |
| LIG3 | DNA ligase III; involved in base excision repair and mitochondrial DNA maintenance | Distinct from ligase IV; used for comparative studies [3,4] |
| TP53BP1 | DNA damage response protein; promotes NHEJ | Influences pathway choice; not a core component but functionally linked |
| ATM | Kinase that activates DNA damage response; promotes NHEJ | Regulates repair; not a core component but important context |
| DNA-PKcs | Kinase that activates NHEJ; interacts with Ku | Essential for NHEJ; not in core complex but required for function |
| ARTEMIS | Nuclease involved in end processing during NHEJ | Processes hairpin ends; not a core component but functionally associated |
| XLF (Cernunnos) | Stimulates ligation by XRCC4-LIG4 | Mutations cause immunodeficiency; not in core complex but interacts |
| PAXX | Paralog of XRCC4; promotes NHEJ | Recently identified; not in core complex but functionally redundant |
| MRI | Component of the MRN complex; involved in DNA damage response | Not in core complex but influences NHEJ |
| NBS1 | Component of the MRN complex; involved in DNA damage response | Not in core complex but influences NHEJ |
How Is DNA ligase IV complex Regulated?
The DNA ligase IV complex is regulated at multiple levels. Its recruitment to DNA breaks depends on the Ku70/Ku80 heterodimer, which directly interacts with XRCC4. Post-translational modifications, such as phosphorylation by DNA-PKcs, can modulate the activity of the complex, although the precise mechanisms are still being elucidated. Additionally, the choice between NHEJ and homologous recombination is influenced by factors such as TP53BP1 and ATM, which can affect the utilization of the ligase IV complex. The complex also interacts with other repair proteins, such as XLF and PAXX, which stimulate its ligation activity. Furthermore, catalytically inactive ligase IV can still promote repair, suggesting that non-catalytic functions are regulated independently.
DNA ligase IV complex and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LIG4 | LIG4 syndrome (immunodeficiency, radiosensitivity, growth retardation) | Knockout or point-mutation knock-in in human cell lines (e.g., HEK293T, HCT116) [1,2] |
| XRCC4 | XRCC4 deficiency (immunodeficiency, short stature) | Knockout in human cell lines; complementation with wild-type or mutant XRCC4 |
| KU70/KU80 | Radiosensitivity, immunodeficiency | Knockout in human cell lines; re-expression of wild-type or mutant Ku |
| POLB | Cancer predisposition, DNA repair defects | Knockout in mouse models or human cell lines; combined with LIG4 knockout |
| XRCC1 | Cancer predisposition, PARP inhibitor sensitivity | Knockout in human cell lines; study of PARP1 trapping |
Immunodeficiency and radiosensitivity
Mutations in LIG4 or XRCC4 cause a spectrum of human diseases characterized by severe combined immunodeficiency, radiosensitivity, and growth retardation [1,2]. These defects arise because the DNA ligase IV complex is essential for V(D)J recombination, which generates diverse antigen receptors. Cells from affected individuals are hypersensitive to ionizing radiation and chemotherapeutic agents that induce double-strand breaks.
Cancer predisposition and genome instability
Dysfunction of the DNA ligase IV complex leads to genomic instability and increased cancer predisposition [1,2]. Loss of ligase IV activity results in the accumulation of DNA breaks and chromosomal aberrations, which can drive tumorigenesis. Moreover, cancer cells often rely on NHEJ for survival, making the complex a potential therapeutic target.
Neurological and developmental disorders
Defects in NHEJ, including those affecting the DNA ligase IV complex, are associated with neurological abnormalities and developmental delay. This is likely due to the importance of DNA repair in post-mitotic neurons, which are particularly vulnerable to DNA damage.
From DNA ligase IV complex-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does LIG4 catalytic activity require its ligase domain for NHEJ? | Point mutation (catalytically inactive LIG4 knock-in) |
| What is the structural role of LIG4 in NHEJ fidelity? | Knock-in of separation-of-function mutants |
| How does XRCC4 stabilize LIG4? | Knockout of XRCC4 with re-expression of binding mutants |
| What are the genetic interactions between LIG4 and POLB? | Double knockout of LIG4 and POLB in human cells |
| How is the complex recruited to DNA breaks? | Tagged knock-in of LIG4 or XRCC4 for live-cell imaging |
| Can overexpression of LIG4 rescue repair defects? | Overexpression of wild-type or mutant LIG4 in knockout cells |
How to Study the DNA ligase IV complex Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identify genes required for resistance to DNA damage |
| Live-cell imaging | Recruitment kinetics and localization | Visualize LIG4/XRCC4 foci at DNA breaks |
| Affinity purification-mass spectrometry | Protein-protein interactions | Map the interactome of the complex |
| NHEJ reporter assay | Efficiency and fidelity of end joining | Assess repair defects in mutant cells [1,2] |
| Western blot | Protein expression and stability | Validate knockout or knockdown efficiency |
| Comet assay | DNA break accumulation | Measure repair capacity after damage |
| V(D)J recombination assay | Immunoglobulin/T-cell receptor rearrangement | Assess immune cell development |
| CRISPR base editing | Introduction of point mutations | Create catalytically inactive LIG4 mutants |
CRISPR-Cas9 knockout screens
Genome-wide CRISPR knockout screens can identify genes that are essential for resistance to DNA-damaging agents, including components of the DNA ligase IV complex. Such screens have revealed synthetic lethal interactions and pathways that compensate for loss of NHEJ.
Live-cell imaging of repair foci
Tagging LIG4 or XRCC4 with fluorescent proteins allows real-time visualization of their recruitment to DNA damage sites. This approach provides insights into the kinetics and dynamics of complex assembly.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry can identify novel interactors of the DNA ligase IV complex and map its interaction network. Such studies help define the composition and regulation of the complex.
Functional assays for NHEJ
Reporter-based assays, such as those using I-SceI-induced breaks, measure the efficiency and fidelity of NHEJ in cells with mutations in complex components [1,2]. These assays are critical for linking genotype to repair phenotype.
How CRISPR Can Be Used to Study GO:0032807 DNA ligase IV complex
Knockout
CRISPR-Cas9 knockout of LIG4 or XRCC4 in human cell lines abolishes NHEJ and causes hypersensitivity to DNA-damaging agents [1,2]. These models are used to study the essential functions of the complex and to identify compensatory pathways.
Point Mutation
Point mutations that inactivate the catalytic activity of LIG4 (e.g., in the active site) can be introduced by CRISPR base editing or homology-directed repair. Such models have revealed that catalytically inactive LIG4 can still promote repair, highlighting non-catalytic functions.
Knock-in
Knock-in of tagged versions of LIG4 or XRCC4 (e.g., GFP or HaloTag) allows live-cell imaging and proteomic studies. Knock-in of separation-of-function mutants helps dissect the structural versus catalytic roles of the complex.
Overexpression
Overexpression of wild-type or mutant LIG4 can rescue or exacerbate repair defects in knockout cells. This approach is useful for structure-function studies and for testing the effects of disease-associated mutations.
How EDITGENE Supports DNA ligase IV complex Research
Researchers studying DNA ligase IV complex-related genes often need to determine whether a candidate gene is causally involved in NHEJ, genome stability, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional studies of the DNA ligase IV complex and its interacting partners.
Contact EDITGENE today to design your custom CRISPR model for DNA ligase IV complex research.
Frequently Asked Questions About DNA ligase IV complex
What is the DNA ligase IV complex?
The DNA ligase IV complex (GO:0032807) is a protein complex that contains DNA ligase IV and XRCC4 (or its yeast homolog Lif1p) and is essential for DNA repair by non-homologous end joining.
What genes are involved in the DNA ligase IV complex?
The core genes are LIG4 (encoding DNA ligase IV) and XRCC4; other associated factors include KU70, KU80, XLF, and PAXX.
What is the function of GO:0032807?
It is a cellular component term describing a complex that carries out the ligation step of non-homologous end joining, thereby repairing DNA double-strand breaks.
How is the DNA ligase IV complex recruited to DNA breaks?
The Ku70/Ku80 heterodimer binds to DNA ends and directly interacts with XRCC4, recruiting the ligase IV complex to the damage site.
What diseases are associated with DNA ligase IV complex mutations?
Mutations in LIG4 or XRCC4 cause immunodeficiency, radiosensitivity, growth retardation, and cancer predisposition [1,2].
Can DNA ligase IV function without catalytic activity?
Yes, catalytically inactive DNA ligase IV can still promote DNA repair in living cells, indicating non-catalytic roles.
What is the role of XRCC4 in the complex?
XRCC4 is an essential partner that stabilizes DNA ligase IV and stimulates its ligation activity.
How can I study the DNA ligase IV complex using CRISPR?
CRISPR knockout, point mutation, knock-in, and overexpression models can be used to dissect the functions of LIG4 and XRCC4 in human cells [1,2].
What is the difference between DNA ligase IV and DNA ligase III?
DNA ligase IV is dedicated to NHEJ, while DNA ligase III functions in base excision repair and mitochondrial DNA maintenance [3,4].
Why is the DNA ligase IV complex important for cancer research?
Cancer cells often rely on NHEJ for survival; targeting the complex may sensitize tumors to DNA-damaging therapies.
Conclusion
The DNA ligase IV complex (GO:0032807) is a central player in non-homologous end joining, the primary pathway for repairing DNA double-strand breaks in human cells. Its core components, DNA ligase IV and XRCC4, are essential for V(D)J recombination, genome stability, and resistance to DNA-damaging agents [1,2]. Beyond its catalytic ligation activity, the complex has structural roles that influence repair fidelity and end-processing choice [2,7]. Dysregulation of the complex leads to immunodeficiency, radiosensitivity, and cancer predisposition, making it a compelling target for therapeutic intervention [1,2]. CRISPR-based cell models are indispensable for dissecting the molecular mechanisms of this complex and for identifying new vulnerabilities in cancer and immune disorders [1,2,5].
References
- 1. Goff NJ et al.. 2022. Catalytically inactive DNA ligase IV promotes DNA repair in living cells.. Nucleic Acids Res 50(19):11058-11071 PMID: 36263813
- 2. Stinson BM et al.. 2024. Structural role for DNA Ligase IV in promoting the fidelity of non-homologous end joining.. Nat Commun 15(1):1250 PMID: 38341432
- 3. Qin LN et al.. 2025. Extrachromosomal DNA biogenesis is dependent on DNA looping and religation by YY1-Lig3-PARylation complex.. Mol Cell 85(16):3090-3107.e11 PMID: 40769147
- 4. Tostes K et al.. 2022. Autophagy deficiency abolishes liver mitochondrial DNA segregation.. Autophagy 18(10):2397-2408 PMID: 35220898
- 5. Kurosawa A et al.. 2020. Complex genetic interactions between DNA polymerase β and the NHEJ ligase.. FEBS J 287(2):377-385 PMID: 31330087
- 6. Demin AA et al.. 2021. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair.. Mol Cell 81(14):3018-3030.e5 PMID: 34102106
- 7. Conlin MP et al.. 2017. DNA Ligase IV Guides End-Processing Choice during Nonhomologous End Joining.. Cell Rep 20(12):2810-2819 PMID: 28930678
- 8. Nick McElhinny SA et al.. 2000. Ku recruits the XRCC4-ligase IV complex to DNA ends.. Mol Cell Biol 20(9):2996-3003 PMID: 10757784
